Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Lymphoid 4Thoracic 3Gastrointestinal 2Breast 2Gynecologic 1Genitourinary 1Endocrine 1Classical hematology 1

Conditions

Breast Neoplasms 2936Neoplasms 174Lung Neoplasms 149Prostatic Neoplasms 116Ovarian Neoplasms 113Colorectal Neoplasms 106Triple Negative Breast Neoplasms 98Colonic Neoplasms 91Neoplasm Metastasis 74Melanoma 66Carcinoma, Non-Small-Cell Lung 64Pancreatic Neoplasms 63Carcinoma, Intraductal, Noninfiltrating 60Stomach Neoplasms 54Head and Neck Neoplasms 47Breast Cancer Female 45Lymphedema 42Uterine Cervical Neoplasms 40Breast Carcinoma In Situ 35Esophageal Neoplasms 34Cardiotoxicity 34Urinary Bladder Neoplasms 33Motor Activity 33Lymphoma 33Endometrial Neoplasms 33Breast Diseases 33Fatigue 30Rectal Neoplasms 28Breast Neoplasms, Male 28Multiple Myeloma 27

Interventions

Vaccines 1Surveys and Questionnaires 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Lymphadenopathy × Breast × Clear all
NCT04872738 2026-01-06

LymphVAX

Massachusetts General Hospital

Completed
714 enrolled 7 charts
Breast

Lymphadenopathy, Breast Cancer Lymphedema, COVID-19, Breast Neoplasms

NCT06429020 2024-05-24

Sonography for COVID-19 Vaccines Related Reactive Lymphadenopathy

Chimei Medical Center

Completed
1,089 enrolled
Breast

Lymphadenopathy, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡